Company
Focus Pharmaceuticals is a rapidly growing, privately owned, independent UK generic pharmaceutical company.
Company latest
News and press
September 2009
New Product Launch – Ondansetron Oral Liquid…
Focus is pleased to announce the launch of Ondansetron Oral Liquid 4mg per 5ml to the market…
Full storyFocus Pharmaceuticals
Founded in 2003, it has achieved significant growth since formation, achieving sales of £13.2m in 2008, with double digit growth forecast for 2009. Such dynamic growth, in a stagnant UK market, is achieved through a highly experienced sales team and selective product choice.
Focus specialise in the licensing and marketing of niche generic products in the UK. The company's range currently comprises of 60 different molecules, in eight different types of formulation.
As well as developing and maintaining its licences, the Focus technical team ensure that Focus is fully compliant with all the relevant regulations relating to GMP, GDP, GCP and PV.
Focus has the proven ability to achieve profitable generic sales in the highly competitive UK generic market. It successfully markets both its own products and also works with a number of generic and brand companies managing their products in the UK.
Focus is a member of the British Generic Manufacturers Association (BGMA).